Analyzing Tecan Group (OTCMKTS:TCHBF) and Nephros (NASDAQ:NEPH)

Tecan Group (OTCMKTS:TCHBF) and Nephros (NASDAQ:NEPH) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations and dividends.

Valuation & Earnings

This table compares Tecan Group and Nephros’ gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tecan Group	N/A	N/A	N/A	$4.27	93.68
Nephros	$14.24 million	1.62	-$1.58 million	($0.15)	-14.60

Tecan Group has higher earnings, but lower revenue than Nephros. Nephros is trading at a lower price-to-earnings ratio than Tecan Group, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

46.8% of Tecan Group shares are owned by institutional investors. Comparatively, 41.1% of Nephros shares are owned by institutional investors. 4.1% of Nephros shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Tecan Group and Nephros’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tecan Group	N/A	N/A	N/A
Nephros	-11.06%	-18.25%	-14.29%

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Tecan Group and Nephros, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tecan Group	0	0	0	0	N/A
Nephros	0	0	0	0	N/A

Summary

Tecan Group beats Nephros on 6 of the 8 factors compared between the two stocks.

About Tecan Group

Tecan Group AG provides laboratory instruments and solutions for pharmaceutical, biotechnology and in-vitro diagnostic companies, university research departments, and diagnostic and other laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and antibodies, and software; and Tecan Labwerx, an automation solution. It provides PARAMIT, a contract design and manufacturing service. The company operates in Switzerland, Europe, Other European countries, North America, Asia, and internationally. Tecan Group AG was founded in 1980 and is headquartered in Männedorf, Switzerland.

About Nephros

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.